Literature DB >> 26181358

JAK/STAT Pathway Inhibitors and Neurologic Toxicity: Above All Else Do No Harm?

Bart L Scott1, Pamela S Becker2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26181358     DOI： 10.1001/jamaoncol.2015.1591

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  2 in total

1.  A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis.

Authors:  S Verstovsek; M Talpaz; E Ritchie; M Wadleigh; O Odenike; C Jamieson; B Stein; T Uno; R A Mesa
Journal:  Leukemia       Date:  2016-08-01       Impact factor: 11.528

2.  An integrative machine learning approach for prediction of toxicity-related drug safety.

Authors:  Artem Lysenko; Alok Sharma; Keith A Boroevich; Tatsuhiko Tsunoda
Journal:  Life Sci Alliance       Date:  2018-11-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.